Evidence map›Paper›PMID 20336153›Full record

ReviewNature reviews. Immunology2010

Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Karsten Sauer, Michael P Cooke

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Predictive modeling of ARDS mortality integrating biomarker/cytokine, clinical and metabolomic data.Translational research : the journal of laboratory and clinical medicine · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Differentiation and homeostasis of effector Treg cells are regulated by inositol polyphosphates modulating CaProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Karsten SauerDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California 92037, USA. ksauer@scripps.edu
Michael P Cooke
Scripps Research Institute · US

Funding

Inositol-Trisphosphate Kinase B (ItpkB) in T Cell Development and FunctionR01AI070845 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SAUER, KARSTEN · 2008 to 2012
$3.0M
Integrated Functional Genomics Analysis of Druggable T Cell-Activating GenesR01GM088647 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SAUER, KARSTEN · 2009 to 2010
$760k
NIAID NIH HHS AI070845NIAID NIH HHS R01 AI070845NIGMS NIH HHS GM088647NIGMS NIH HHS R01 GM088647
6 · The paper itself

Abstract

The membrane lipid phosphatidylinositol-3,4,5-trisphosphate (PtdInsP(3)) regulates membrane receptor signalling in many cells, including immunoreceptor signalling. Here, we review recent data that have indicated essential roles for the soluble PtdInsP(3) analogue inositol-1,3,4,5-tetrakisphosphate (InsP(4)) in T cell, B cell and neutrophil development and function. Decreased InsP(4) production in leukocytes causes immunodeficiency in mice and might contribute to inflammatory vasculitis in Kawasaki disease in humans. InsP(4)-producing kinases could therefore provide attractive drug targets for inflammatory and infectious diseases.

Indexed as

Cell DifferentiationHumansImmune SystemInositol PhosphatesLeukocytesSignal Transductioninositol-1,3,4,5-tetrakisphosphateInositol Phosphates

Identifiers

PMID20336153
PMCPMC2922113
OpenAlexW2017361318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.